1. What are pharma stocks, and why should you consider stocks priced under ₹200?

Pharma stocks represent companies in the pharmaceutical and healthcare sector, involved in manufacturing drugs, medical devices, and related services. Stocks priced under ₹200 provide an affordable entry point, especially for beginner investors, and can include companies with significant growth potential in the future.

2. Which pharma stocks under ₹200 are currently performing well in India?

Some of the top-performing pharma stocks under ₹200 include companies like Sun Pharma Advanced Research, Aarti Drugs, and Granules India. These companies have shown consistent performance and are considered good options in the affordable range.

3. What are the risks of investing in low-priced pharma stocks?

Risks include market volatility, regulatory changes, competition from larger players, and dependency on drug approvals. Low-priced stocks may also have limited liquidity and higher susceptibility to market fluctuations, making them riskier investments.

4. How do government regulations impact the pharma sector?

Government regulations can significantly impact the profitability of pharmaceutical companies. Policies related to drug pricing, export-import tariffs, and quality standards can influence revenues. Favorable policies can drive growth, while stricter regulations might pose challenges.

5. How can you diversify your portfolio with pharma stocks under ₹200?

Diversification can be achieved by investing in companies across different sub-sectors, such as generic drugs, biotechnology, and medical devices. This reduces risk by spreading investments over various segments of the pharma industry.

6. What are the growth prospects of pharma companies with low stock prices?

Growth prospects depend on factors like increasing healthcare demand, expansion into global markets, investments in research and development, and government initiatives to promote the pharmaceutical sector. Companies with innovative products and strong pipelines often have high growth potential.

Best Pharma Stocks Under Rs. 200

Pharma stocks are shares of pharmaceutical companies that are listed on NSE/BSE. Here’s the list of top pharma stocks under Rs. 200.

Best Pharma Stocks Under Rs. 200 in India

Analyse Pharma stocks further

Visit 'Pharma Stocks' Screener

Overview of the Top Pharma Stocks Under Rs. 200

Sun Pharma Advanced Research Co Ltd

Sun Pharma Advanced Research Co Ltd specialises in pharmaceutical research and development, focusing on innovative drug delivery systems and novel formulations. It is a leading player in advancing therapeutic solutions, particularly in the areas of oncology, neurology, and dermatology.

SeQuent Scientific Ltd

SeQuent Scientific Ltd is a global animal health company that develops, manufactures, and markets veterinary pharmaceutical products. With a strong focus on formulations and APIs, the company addresses the needs of livestock and poultry healthcare worldwide.

Morepen Laboratories Ltd

Morepen Laboratories Ltd operates in the healthcare and pharmaceutical space, producing active pharmaceutical ingredients (APIs), formulations, diagnostics, and OTC products. Its signature offerings include healthcare essentials like medical devices and wellness products.

Alembic Ltd

Alembic Ltd is a diversified conglomerate with a core focus on pharmaceuticals, real estate, and power generation. Its pharmaceutical arm emphasises manufacturing formulations and APIs, serving both domestic and international markets.

Suven Life Sciences Ltd

Suven Life Sciences Ltd is a biopharmaceutical company engaged in drug discovery and development. Specialising in treatments for central nervous system disorders, it is at the forefront of research in neurological and psychiatric therapeutic areas.

Advantages of Investing in Pharma Stocks Under Rs. 200 in India

Unlocking Growth Potential

Investing in low price pharma stocks in India offers an exciting opportunity for rapid and significant growth. A drug trial or regulatory approval breakthrough from even lesser-known pharmaceutical companies in India can skyrocket the stock’s value, delivering substantial returns to investors even with modest initial investments.

Driving Innovation

By backing pharma sector stocks, investors become integral players at the forefront of medical progress. Beyond financial gains, they actively contribute to advancing groundbreaking healthcare solutions with the potential to save lives.

Accessible Market Entry

With their low share prices, pharma stocks India provide a minimal-cost gateway to market entry. This accessibility empowers investors, especially those with limited capital, to spread their investments across multiple promising healthcare ventures, effectively diversifying their portfolios.

Riding Regulatory Waves

Positive regulatory events, such as patent approvals or clearances from the Department of Pharmaceuticals, often trigger surges in the value of these healthcare penny stocks. Savvy investors seize the opportunity to capitalise on these moments, leveraging them as catalysts for potential stock appreciation.

Download Now

Factors to Consider Before Investing in Pharma Stocks Under Rs. 200

Company Fundamentals

Assess the company's financial health by examining metrics like revenue growth, profit margins, and debt levels to ensure stability and potential for growth.

Regulatory Compliance

Ensure the company adheres to industry regulations and maintains quality standards, as non-compliance can lead to legal issues and financial losses.

Product Portfolio

Evaluate the diversity and innovation within the company's product line, focusing on drugs in high-demand therapeutic areas to gauge future revenue streams.

Competitive Positioning

Analyse the company's market share and competitive advantages within the pharmaceutical sector to understand its ability to sustain profitability.

Popular Stock Collections

Popular Mutual Fund Collections

Frequently Asked Questions on Pharma Stocks Under Rs. 200

1. What are pharma stocks, and why should you consider stocks priced under ₹200?
Pharma stocks represent companies in the pharmaceutical and healthcare sector, involved in manufacturing drugs, medical devices, and related services. Stocks priced under ₹200 provide an affordable entry point, especially for beginner investors, and can include companies with significant growth potential in the future.
2. Which pharma stocks under ₹200 are currently performing well in India?
Some of the top-performing pharma stocks under ₹200 include companies like Sun Pharma Advanced Research, Aarti Drugs, and Granules India. These companies have shown consistent performance and are considered good options in the affordable range.
3. What are the risks of investing in low-priced pharma stocks?
Risks include market volatility, regulatory changes, competition from larger players, and dependency on drug approvals. Low-priced stocks may also have limited liquidity and higher susceptibility to market fluctuations, making them riskier investments.
4. How do government regulations impact the pharma sector?
Government regulations can significantly impact the profitability of pharmaceutical companies. Policies related to drug pricing, export-import tariffs, and quality standards can influence revenues. Favorable policies can drive growth, while stricter regulations might pose challenges.
5. How can you diversify your portfolio with pharma stocks under ₹200?
Diversification can be achieved by investing in companies across different sub-sectors, such as generic drugs, biotechnology, and medical devices. This reduces risk by spreading investments over various segments of the pharma industry.
6. What are the growth prospects of pharma companies with low stock prices?
Growth prospects depend on factors like increasing healthcare demand, expansion into global markets, investments in research and development, and government initiatives to promote the pharmaceutical sector. Companies with innovative products and strong pipelines often have high growth potential.